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Intestinal epithelial barrier plays a critical role in the maintenance of gut homeostasis by limiting the penetration of luminal
bacteria and dietary allergens, yet allowing antigen sampling for the generation of tolerance. Undigested proteins normally do
not gain access to the lamina propria due to physical exclusion by tight junctions at the cell-cell contact sites and intracellular
degradation by lysosomal enzymes in enterocytes. An intriguing question then arises: how do macromolecular food antigens
cross the epithelial barrier? This review discusses the epithelial barrier dysfunction in sensitized intestine with special emphasis
on the molecular mechanism of the enhanced transcytotic rates of allergens. The sensitization phase of allergy is characterized by
antigen-induced cross-linking of IgE bound to high aﬃnity FcεRI on mast cell surface, leading to anaphylactic responses. Recent
studies have demonstrated that prior to mast cell activation, food allergens are transported in large quantity across the epithelium
and are protected from lysosomal degradation by binding to cell surface IgE and low-aﬃnity receptor CD23/FcεRII. Improved
immunotherapies are currently under study including anti-IgE and anti-CD23 antibodies for the management of atopic disorders.
1.Introduction
Foodallergyisreportedin6–10%ofthepediatricpopulation
and is more frequent in children than adults [1, 2]. The
most common allergens include cow’s milk, eggs, peanuts,
and seafood. Although some types of food allergy remit
spontaneously during the ﬁrst few years of life, it is often
associated with later development of extraintestinal allergies
that manifest in the respiratory tract and skin [1, 2].
The sensitization phase of allergy is characterized by
increased IgE synthesis and Th2-type cytokine (IL-4, IL-
5, and IL-13) responses. Elevated production of IL-4 by
mononuclear cells has been demonstrated in the blood and
intestinal mucosa of atopic individuals [3, 4]. IL-4 induces
germ line ε transcription for isotype class switching in B cells
and promotes B cell proliferation to increase the synthesis of
antigen-speciﬁc IgE [5]. In addition to its presence in serum,
elevated levels of allergen-speciﬁc IgE are detected in the
intestinalﬂuidandstoolsamplesinfood-allergicpatients[6–
8]. The presence of IgE in the gut lumen was also observed
in parasitic infection animal models infected with parasites
[9]. The binding of IgE to the high aﬃnity FcεRI on the
surface of mast cells is the hallmark of allergy. Cross-linking
ofIgEbyspeciﬁcantigeninducesmastcelldegranulationand
release of mediators, thereby, causing anaphylactic responses
[10]. Anaphylactic reactions in food allergy are associated
with enhanced epithelial ion transport with passive outﬂux
of water which is responsible for clinical diarrheal symptoms
[11, 12]. The release of mast cell mediators, for example,
histamine, prostaglandin, and serotonin, is involved in the
stimulation of epithelial ion secretion [13, 14].
2. Immunopathogenesis of Intestinal
Sensitization: Role of Bacterial Products and
IntestinalEpithelialCells
A number of factors are involved in the onset of food
sensitization, including genetic traits, allergen exposure,
and environmental stimuli. Other factors that aﬀect the
outcome of allergic diseases include the age at which
food antigen is introduced, formula versus breast-feeding,2 Journal of Allergy
dietary composition, and gastrointestinal infection status.
Recent evidence has implicated a critical role of intestinal
microﬂora in the developmental stage of food allergy. In
healthy individuals, the colonic lumen hosts over 100 trillion
commensal bacteria, the microﬂoral composition of which
is established during the neonatal period by exposure to
vaginal microbes through the birth canal or to bacteria of
the digestive tract of the mother via food ingestion [15, 16].
Commonly identiﬁed enteric commensal bacteria include
those in the phyla Firmicutes (species such as Lactobacillus,
Clostridium, Enterococcus) ,B a c t e r o i d e t e s( s p e c i e ss u c ha s
Bacteroides), Proteobacteria (species such as Escherichiacoli),
and Actinobacteria (species such as Biﬁdobacteria)[ 17, 18].
These bacteria are traditionally viewed as cohabitant organ-
isms in the gut that only require elimination in cases where
abnormal translocation to systemic blood or extraintestinal
organs occurs. It was only recently that our coevolved
microorganisms have started to be viewed in a more positive
light, with more and more evidence of their beneﬁcial
eﬀects to the host [16, 19]. It is now generally believed
that the enteric microbiota is involved in the regulation
of multiple physiological functions in the gastrointestinal
tract. These include competition with and the reduction
of pathogen colonization, the degradation of nondigestible
dietary substances, the production of short chain fatty acids,
folic acids and vitamins, and the stimulation of normal
epithelial turnover, as well as the shaping of the mucosal
immunity [16, 19–21].
Evidence gathered in germ-free and gnotobiotic mouse
models led to the identiﬁcation of another beneﬁcial role
of gut bacterial ﬂora, the induction of oral tolerance.
The term “oral tolerance” has been deﬁned as a systemic
immuneunresponsivenesstoaspeciﬁcantigenthathadbeen
previously administered via the oral route. The breakdown
of oral tolerance has been suggested to be involved in the
pathogenesis of food allergy. In contrast to conventionally
raised animals, germ-free mice do not generate immune
tolerance against fed antigens [22, 23]. The Th1-mediated
responses such as the production of IgG2a and IFNγ were
abolishedwhiletheTh2-mediatedsynthesisofIgE,IgG1,and
IL-4 remained high in germ-free mice orally administered
ovalbumin as a tolerogen before a systemic challenge with
the same protein [22]. Interestingly, oral tolerance may be
restored in germ-free mice by inoculation with a single
strain of commensal bacteria such as Escherichia coli or
Biﬁdobacterium infantis [23]. Moreover, mice given oral
antibiotics that cause commensal depletion during infancy
displayed increased plasma levels of IgG1 and IgE, and
decreased IgG2a, in parallel with enhanced IL-4 secretion
in stimulated spleen cells [24]. The polarized Th2 immune
responses in antibiotic-treated mice were reversed by sup-
plementation with Enterococcus faecalis, and to a lesser
extent with Lactobacillus acidophilus [25]. These ﬁndings
underscore the role of intestinal commensal bacteria in the
induction of oral tolerance and the prevention of allergy.
Signaling receptors activated by microbe-associated
molecular pattern (MAMP) may regulate the host suscepti-
bility to food allergy. Polymorphism of CD14, the binding
receptor for lipopolysaccharide, has been associated with the
development of nonatopic asthma and food allergy [26–
28]. However, other studies found no evidence of gene
polymorphism of CD14, toll-like receptor (TLR)-2 and -4
in food allergic diseases [29, 30]. Another study demon-
strated increased production of tumor necrosis factor-
alpha and interleukin-1 in cord blood mononuclear cells
upon TLR2, TLR4, and TLR5 activation in newborns who
later develop allergic diseases, suggesting a link between
heightened perinatal TLR response and allergy development
[31]. Using animal models lacking functional TLR4 in C3H
micebackground,itwasdemonstratedthatTLR4-dependent
signals provided by intestinal commensal bacteria inhibit the
developmentofallergicsensitization,includingTh2-skewing
responses and anaphylaxis to peanut allergens [32, 33]. It is
worth noting that both intestinal epithelial cells and lamina
propria macrophages express CD14 and TLR4 at variable
levels that change in intestinal inﬂammation [34, 35]. The
role of MAMP signaling by epithelial cells and/or innate
immune cells in the mechanism of allergic sensitization is
still poorly understood.
The putative concept underlying development of oral
tolerance is that feeding antigen at a high dosage results
in clonal deletion or anergy of speciﬁc T cell clones in a
process that involves Fas/FasL-dependent apoptosis, whereas
low antigen dosage favors the pathway of active suppression
following the induction of regulatory T (Treg) cells [36].
The diﬀerent means of tolerance induction are not mutually
exclusive but may overlap. Diﬀerent subsets of dendritic
cells have been described in the mouse intestine based on
their expression of surface molecules such as CD11b, CD11c,
CD103, CX3CR1, and CD70; these subsets have their own
functional specialization that are crucial for determining the
induction of immunity or tolerance to gut antigens [37].
For example, certain subtypes of dendritic cells are involved
in the diﬀerentiation of Th1, Th2, and Th17 cells, or are
required for isotype switching of IgA in B cells [37–40]. On
theotherhand,tolerogenicCD103(+)dendriticcellsisolated
fromthelaminapropriaormesentericlymphnodesdrivethe
development ofTregcellsthatarecrucialfortheinduction of
oral tolerance [41, 42].
Recent advances have indicated that intestinal epithelial
cells play critical roles in promoting the diﬀerentiation of
dendritic subsets with tolerogenic phenotypes, suggesting
that the local microenvironment is important for driving
oral tolerance. Recent studies have indicated that epithelial-
derived transforming growth factor (TGF)-β and retinoic
acid were required for the upregulation of CD103 on
dendritic cells, and the epithelial-conditioned dendritic cells
areinturncapableofinducingthediﬀerentiationofadaptive
Foxp3+ Treg cells with gut-homing properties [43, 44].
Others have reported that the expression of integrin αvβ6
in epithelial-derived exosomes, when coupled with food
antigen, results in the development of TGFβ-producing
tolerogenic dendritic cells that promote active production
of TGFβ in Treg cells [45]. Moreover, a transient break
of epithelial barrier caused by ethanol or a Vibrio cholerae
zonula occludens toxin hexapeptide induced the develop-
ment of Treg cells through mechanisms that requires the
presence of an intact microﬂora and dendritic cells [46].Journal of Allergy 3
These ﬁndings suggest that intestinal epithelial cells are in-
volved in the development of tolerogenic dendritic cells and
Treg cells that are central for the induction of oral tolerance.
As feeding of antigen alone leads to oral tolerance, the
administrationoffoodproteinswithbacterialadjuvantssuch
as pertussis toxin and cholera toxin is used to sensitize ani-
mals instead [47–50]. Coadministration of bacterial-derived
toxins with antigens was shown to upregulate the expression
of MHCII and costimulatory molecules on monocyte- and
bone marrow-derived dendritic cells, and to induce a Th2-
skewing response with elevated production of IL-4 and
increased synthesis of antigen-speciﬁc IgE and IgG2a [51,
52]. Accumulating data indicate that bacterial adjuvants
may aﬀect the intestinal dendritic cells population. A recent
report documented that cholera toxin induce the selective
expansion of CD11c(+) dendritic cell subsets and increased
maturation of all subsets of dendritic cells associated with
upregulatedOX40ligandexpressioninthemesentericlymph
nodes and consequent promotion of Th2-driven responses.
The authors suggest that the OX40L molecule may play a
critical role in sensitization to food allergens [53]. Another
study indicated that exposure to cholera toxins induces
allergic sensitization to peanut extracts by causing a shift
of the subsets of dendritic cells in the lamina propria and
Peyer’s patches with more inﬂammatory CD11b(+) and
fewer tolerogenic CD103(+) cells [54]. Moreover, increased
expression of T-cell immunoglobulin and mucin domain
molecule (TIM)-4 was found in mouse bone marrow-
derived dendritic cells in vitro after concurrent exposure
to cholera toxins and peanut allergens compared to those
treated with allergens alone [55]. Adoptive transfer of these
TIM4-expressing dendritic cells sensitizes na¨ ıve mice to
orally challenged peanut allergens, as evidenced by height-
ened Th2 cytokine responses and elevated levels of speciﬁc
antibodies of IgE in the serum and intestinal tissues [55].
The interaction between TIM1 expressed on CD4(+) T cells
and TIM4 expressed on dendritic cells has been suggested to
play an important role in the polarization of Th2 responses
and the inhibition of tolerance development [56, 57].
Similar eﬀects of TIM4 overexpression in intestinal mucosal
dendritic cells and intestinal sensitization to ovalbumin were
reported after exposure to staphylococcal enterotoxin B as
the adjuvant [58]. These ﬁndings all point to the regulatory
role of intestinal dendritic cells in the determination of
the nature of antigen-speciﬁc T cell diﬀerentiation, and the
induction of Th2 skewing caused by bacterial toxins for
allergic sensitization to food proteins.
3.IntestinalEpithelialBarrierFunctions
The luminal surface of the gastrointestinal tract from the
stomach to the rectum is covered by a single layer of
epithelialcells.Thevastepithelialsurfaceofthegutallowsfor
eﬃcient nutrient uptake of energy sources in the individual.
However, the epithelial layer must also form a competent
line of defense since it is constantly bombarded with
noxious luminal contents, such as antigenic substances and
pathogens. The epithelial layers are maintained in a dynamic
equilibrium governed by the balance between crypt stem
cell proliferation and villus/surface cell shedding. The newly
proliferated stem cells in the crypt regions diﬀerentiate into
absorptive and secretive types of epithelial cells with high
expression of brush border enzymes and transporters, and
concurrently migrate upward to the apex of the villi where
cells then undergo apoptosis and detachment [59]. During
thediﬀerentiationprocess,epithelialtightjunctions(TJs)are
formed at the cell-cell contact sites to seal oﬀ gaps between
cells. This physical barrier constituted by the closely linked
epithelial cells is the rate-limiting factor that determines gut
permeability.
The tight junctional complexes forming the most apical
portion of the lateral plasma membrane between two cells
only allowmolecules smallerthanabout 500 Daltons tocross
and exclude the inﬂux of antigenic proteins and bacteria
through paracellular routes. The transmembraneous junc-
tional proteins, for example, claudins, occludin, or junction-
associated molecule (JAM) are linked to intracellular zonula
occludens (ZOs) which are bridges to cytoskeletal actin and
myosin ﬁlaments [60, 61]( Figure 1). The organization of
TJ proteins and perijunctional actinomyosins is regulated
by a complex network of signaling pathways. Contraction
of the actinomyosin ﬁlaments, which opens up paracellular
junctions, is mediated by the phosphorylation of myosin
light chain via the activation of myosin light chain kinase or
Rho-associated kinase [62–64]. In addition to the physical
opening of TJs, Rho-associated kinase also mediates the
endocytosis of TJ proteins into vacuolar apical compart-
ments [64]. Diﬀerent isoforms of protein kinase C (PKC)
are involved in TJ opening and assembly [65]. The atypical
PKCzeta is the sole isoform found at intercellular contact
sites [66, 67]. Previous studies have shown that membrane
translocation and phosphorylation of PKCzeta leads to
decreased transepithelial epithelial resistance and relocation
of ZO-1 and occludin in human intestinal T84 and Caco-
2 cell cultures following infection with enteropathogenic E.
coli [68, 69]. Other reports demonstrated that the activation
of PKCzeta causes the redistribution of occludin away from
the intercellular junctions by direct phosphorylation of this
tight junctional protein [70]. Recent in vivo data have
further supported a critical role of PKCzeta activation in
the disruption of TJs and gut permeability increase in bowel
obstruction models [71].
Structural damage to TJ proteins may also depend on
excessive epithelial cell death in examples of bacterial and
parasitic infection, and in metabolic and inﬂammatory
stress. Numerous pathogens including Helicobacter pylori
[72, 73], enterohemorrhagic E. coli Shiga-like toxin [74],
E. coli lipopolysaccharide [75–77], Salmonella enterica [78],
Citrobacter rodentium [79], and Giardia spp. [80, 81]w e r e
reported to cause epithelial cell apoptosis. It has been
demonstrated that caspases (cellular proteins involved in
the apoptotic cascade) may directly cleave TJ proteins [82].
Metabolic stresses, such as mesenteric ischemia/reperfusion
and hemorrhagic shock, evoke epithelial cell apoptosis and
necrosis that are associated with mucosal barrier dysfunction
and abnormal bacterial translocation [83–88].
Transcellulartransportofparticlesandproteinsislimited
by endosomal degradation within enterocytes. Although4 Journal of Allergy
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Figure 1:Intestinalbarrierfunctions.(a)Diﬀerentiatedintestinalvillousepithelialcellsandthecoveringmucuslayerformaphysicalbarrier
toseparateluminalcontentsfromthelaminapropria.Theepithelialbarrierpreventstheentryofnoxioussubstances,suchasundigestedfood
proteinsandcommensalbacteria,intothebodyproper.(b)Tightjunctionalcomplexeslocatedatthemostapicalportionofthelateralplasma
membrane between two cells excludes the inﬂux of antigenic proteins and bacteria through paracellular routes. The transmembraneous
junctional proteins, for example, claudins, occludin, or junction-associated molecule (JAM), are linked to intracellular zonula occludens
(ZO) which are bridges to perijunctional actinomyosin rings. Most dietary proteins are digested to small peptides and amino acids before
being absorbed into enterocytes via speciﬁc transporters. A very small percentage of intact proteins may be endocytosed into epithelial cells
but are degraded by lysozymes and lose their antigenic properties. The lysosomal degradation pathway thus prevents the entry of intact
proteins through transcellular routes.
a small amount of intact protein may be endocytosed into
epithelialcellsinphysiologicalconditions,mostofitissorted
into lysosomal compartments for degradation, and, there-
fore, transcytosis of whole proteins with antigen properties
is normally prevented [89]. An early study showed that less
than 3% of proteins remain in their intact bioactive form
after luminal-to-basolateral passage across the intestinal
epithelial layer [90].
4.EpithelialBarrierDefects in
IntestinalAllergy
Dietaryproteinsaremostlydigestedbygastricandpancreatic
proteases, as well as by integral brush border enzymes, and
converted to small peptides and amino acids, which are
then absorbed by enterocytes via electrogenic or sodium-
dependent transporters. Undigested proteins usually do not
gain access to the gut lamina propria due to exclusion
by the physical tight junctional barrier and intracellular
degradation by the lysosomal enzymes. Nevertheless, an
apparentdefectinepithelialbarrierwasnotedinfoodallergy.
Early clinical studies in children with cow’s milk allergy
demonstrated intestinal permeability rise after, but not
before,allergenchallenge[91–93].Arecentstudyusingsmall
intestinal biopsy specimens exposed to food allergen in vitro
has shown decreased expression of tight junctional protein,
that is, occluding, claudin-1 and ZO-1, in tissues obtained
from patients with food allergy compared to those from
normal subjects after antigen challenge [94]. These studies
suggest that allergen challenge in sensitized individuals leads
to enhanced intestinal permeability.
Experimental models indicate that the breach of epithe-
lial barrier may be a consequence of Th2 switching or may
possibly reﬂect exaggerated responses and viscous cycles
caused by mast cell activation [10]. Direct eﬀects of type 2
cytokines, for example, IL-4 and IL-13, on the modulation
of intestinal epithelial cell permeability have been demon-
strated in human epithelial cell cultures [95–97]. Both IL-
4 and atopic serum decreased the transepithelial resistance,
and selectively increased the apical-to-basal movement of
a macromolecular protein, that is, horseradish peroxidase,
through both transcellular and paracellular pathways across
the human colonic epithelial T84 monolayer [95, 96]. Others
reported that IL-4 increased the expression of pore-forming
tight junctional protein claudin-2, which correlated with
the enhanced epithelial permeability [98]. Recent studies
have demonstrated that IL-13 decreased the transepithelial
resistanceofhumancolonicepithelialHT29/B6cellsthrough
the induction of cell apoptosis and increased expression of
claudin-2 [99, 100]. Moreover, the involvement of phos-Journal of Allergy 5
phatidylinositol 3-kinase has been identiﬁed in the signaling
pathways of IL-4 and IL-13-increased intestinal epithelial
permeability using cell culture models [96, 97]. There
is also evidence that mediators released from mast cells,
for example, tryptase and tumor necrosis factor (TNF)-
alpha, contribute to the increased epithelial paracellular
permeability [101–104].
Although the link between enhanced permeability in gut
epithelial barrier and food allergy is widely accepted, it is
not clear which one happens ﬁrst during the sensitization
phase. A previous study in rats has shown that chronic psy-
chological stress, which increases uptake of luminal proteins,
may predispose animals to sensitization of orally delivered
antigens [105]. The underlying factors that contribute to
gut barrier defects caused by psychological stress include
corticotrophin-releasing factor and nerve growth factor, as
well as mast cell activation [105–108]. However, psycho-
logical stress also modulates mast-nerve cell interaction
and increases mast cell-dependent bacterial adherence and
uptake in enterocytes as well as follicle-associated epithelium
on Peyer’s patches [109–111]. Therefore, we cannot rule
out the possibility that nerve and bacteria are involved
in the stress-induced intestinal sensitization by altering
immune predisposition. Another report demonstrated that
mast cell-dependent epithelial permeability rise predisposes
mice with IL-9 overexpression to oral antigen sensitization.
The intestinal sensitization may be prevented by mast
cell stabilizer cromolyn that blocks mast cell activity and
intestinal permeability [112]. However, there is no direct
evidence that intestinal barrier dysfunction is the main
initiating factor for intestinal allergic sensitization. The use
of antigens with protease activity for disruption of epithelial
barrier in experimental models may tease out the order
between permeability change and allergic sensitization. A
murine model of allergic respiratory inﬂammation has been
recently developed by repeated intratracheal administration
of proteolytically active Pen c13, a major allergen secreted
by fungal Penicillium citrinum, without the use of adjuvant
[113]. The protease activity of the allergen and the resultant
tight junctional disruption of respiratory epithelial cells were
found associated with the development of airway allergic
sensitization [113]. To date, a direct role of intestinal perme-
ability rises, and luminal antigen leakage in the sensitization
stage of food allergy remains to be established.
5.Mechanismof EnhancedTransepithelial
AntigenTransportinAllergicIntestines
It is generally accepted that intestinal anaphylactic reactions
arecausedbybiologicalmediatorsreleasedfrommastcellsin
the lamina propria after antigen cross-linking of IgE on the
cell surface, suggesting abnormal transepithelial transport
of luminal antigens in food allergy. An intriguing question
then arises: how do macromolecular food antigens cross
the intestinal epithelial barrier? Abnormal antigen passage
throughspecializedlymphoidorgans,thatis,Peyer’spatches,
in the intestinal tract has been suggested as one mechanism
responsible for the lack of tolerance [114–116]. However,
in comparison to the limited exposing area of the Peyer’s
patches, villous epithelium with its much larger relative
surface area may play a more important role in the loss of
barrier integrity in intestinal allergy.
It was ﬁrst noticed in rodent models that the addition of
antigen to the luminal or serosal sides of the allergic intestine
both induces strong ion secretory responses, though with
diﬀerent time frames. Antigen challenge to the serosal side
of the intestine induces an immediate increase (∼30sec) in
ion secretion, whereas luminal addition of antigen results in
a lag phase (∼3min) before the occurrence of the mast cell-
mediated epithelial secretory response [13]. The lag phase
of the anaphylactic response after luminal challenge appears
to reﬂect the time for antigen transport across the intestinal
epithelial cells to activate the underlying mast cells in the
lamina propria [13].
Abundant studies exist that show enhanced transcytotic
rates of intact proteins across the intestinal epithelium in
experimental allergy [117, 118]. Using rat models of food
sensitization, the phenomenon of increased antigen uptake
within the endosomal compartment was observed in jejunal
enterocytes before the occurrence of mast cell activation [48,
117, 119], suggesting that heightened apical-to-basolateral
transcellular transport of allergen is mast cell independent.
This notion was conﬁrmed in studies using sensitized
Ws/Ws rats (mast cell deﬁciency due to the mutation of
the gene c-kit) and mast cell stabilizing agents [119]. The
uptake of antigen appeared to be speciﬁc and the transport
pathway was exclusively transcellular within the ﬁrst 2min
after challenge. This period of speciﬁc transcellular antigen
transport before mast cell activation was termed phase
I[ 48, 119]. The period following mast cell activation,
as evidenced by an epithelial ion secretory response, was
denoted phase II. During phase II, antigens were visualized
notonlyinsideendosomesbutalsowithinthetightjunctions
and paracellular regions between enterocytes in allergic
animals [47, 119]. The electrical conductance (measurement
of ionic permeability through the paracellular pathway) in
intestinal tissues of allergic rats was comparable to that of
nonsensitized control animals during phase I, suggesting
that gut paracellular permeability was not modiﬁed in
response to sensitization per se.M o r e o v e r ,ag r a d u a lt i m e -
dependent increase in tissue conductance corresponds to
the phenomenon of enhanced paracellular antigen transport
in allergic rats during phase II. The abnormal paracellular
epithelial permeability in phase II was absent in allergic mast
cell-deﬁcient Ws/Ws rats, suggesting a crucial role of mast
cell activation in the induction of tight junction opening and
increase of paracellular inﬂux that was not antigen speciﬁc.
The phenomenon of enhanced transepithelial antigen
transport prior to mast cell activation is speciﬁc for the
allergen to which the rodents are sensitized, suggesting an
immunoglobulin recognition mechanism at the epithelial
level [117, 118]. Accumulating evidence suggests that a
low-aﬃnity IgE receptor (CD23/FcεRII) may contribute
to enhanced antigen recognition and rapid transepithelial
transport in allergic animals [11, 47, 48, 90, 120]. CD23 was
previously known for its role in regulating IgE synthesis in
B cells and promoting B cell proliferation [121–123]. CD23
expression was found in small intestinal epithelial cells in6 Journal of Allergy
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Figure 2: IgE/CD23-mediated transepithelial antigen transport in allergic intestines. In food allergy, Th2-skewing and IL-4 synthesis induce
isotype switching in B cells to produce a large amount of IgE that is secreted into serum and gut lumen, or bound to high aﬃnity receptor
FcεRI on mast cell surface. IL-4 also acts on intestinal epithelial cells to upregulate the expression of low-aﬃnity IgE receptor, CD23/FcεRII.
Following exposure to dietary allergens, enhanced luminal-to-serosal transepithelial antigen transport is mediated by IgE/CD23 prior to
mast cell activation during phase I. Transcytosed allergens reach the subepithelial lamina propria and cause IgE cross-linking on mast cells,
resulting in cell degranulation and anaphylactic responses. The release of mast cell mediators, such as histamine, prostaglandin, serotonin
and proteases, are known to induce epithelial ion secretion and to increase paracellular epithelial permeability in phase II.
normal and food-allergic humans and rodents, as well as in
bronchial epithelial cells in asthmatic patients [48, 118, 124].
Studies in sensitized rat models have demonstrated the
translocation of CD23 from the cell surface to the membrane
of allergen-containing endosomes in intestinal epithelial
cells, conﬁrming the internalization of CD23 protein upon
luminalantigenchallenge[118].Furtherstudiesusinggenet-
ically mutant mouse models provided evidence for the role
of IgE/CD23 in mediating enhanced transepithelial antigen
transportinallergy[47,48].Thephenomenonofaugmented
antigen uptake in allergic enterocytes was completely absent
in sensitized CD23−/− mice and IL-4−/− mice. Moreover,
the increased transepithelial antigen uptake in allergic wild-
type mice was inhibited luminally with neutralizing anti-
CD23 antibodies [47, 48]. Passive sensitization of naive mice
by injecting immune serum from allergic mice restored the
allergic response, but not if IgE was ﬁrst depleted from
serum, conﬁrming the crucial role of IgE in antigen uptake.
Inaddition, IL-4increasedtheexpressionofCD23transcript
andprotein levelsin murine intestinal epithelial cellcultures,
as well as allergic mouse enterocytes [48]. These ﬁndings
demonstrate that enhanced transepithelial allergen transport
is mediated by IgE/CD23 and regulated by IL-4 in food
allergy (Figure 2). Recent evidence further supports the
notionthatfoodallergensbindingtoIgE/CD23areprotected
from lysosomal degradation in intestinal epithelium, and
therefore,intactantigenicformsoftheproteinsarepreserved
during transcytosis [120]. It is now clear that IgE/C23 plays
a major role in the mechanism of enhanced transepithelial
antigen uptake that is responsible for later mast cell activa-
tion and anaphylactic responses in experimental models.
Recent studies have indicated that various isoforms of
CD23 mediate bidirectional transport of IgE across the
epithelium in allergic murine and human intestine. DNA
sequencing revealed the presence of classical and alternative
CD23b transcripts lacking exon 5 (bΔ5)o r6( bΔ6) in mouse
enterocytes, all of which were translated into functional IgE
receptorswithdistinctendocyticproperties[47,125].Mouse
intestinal epithelial CD23bΔ5 mediated apical to basolateral
transport of free IgE, whereas classical CD23b displayed
highereﬃciencyinthetranscytosisofIgE/allergencomplexes
[47, 125]. Studies using primary human intestinal epithelial
cells and transformed cell lines have also shown that CD23
transports IgE in both the mucosal-to-serosal and serosal-
to-mucosal directions [126]. Both CD23 isoforms a and b
transfectedintohumanintestinalepithelialcellstranscytosed
IgE bidirectional; however, CD23a transported IgE/antigen
complex faster than CD23b in the apical-to-basolateral
direction [6]. There remains controversy over which isoform
of CD23 is expressed in human enterocytes, and further
evidenceisneededtoconﬁrmtheroleofIgE/CD23-mediated
transepithelial transport in human food allergy [6, 126].
6.NovelDiagnosticandTherapeutic
Developments TargetingCD23
To date, dietary exclusion is still the most eﬀective measure
for the prevention of allergic sensitization and anaphylacticJournal of Allergy 7
responses in high-risk children and adults. The eﬃcacy of
delivering allergen via subcutaneous or sublingual routes for
symptom alleviation still needs to be conﬁrmed by large-
scale blinded, placebo-controlled trials [127]. A therapeutic
approach involving the modulation of dendritic cell func-
tions to disrupt their Th2-skewing ability which has been
proposed for food allergy and allergic rhinitis [53–55, 128,
129]. Other immunotherapies, such as the use of anti-
IgE antibody, have shown some beneﬁts for peanut allergic
patients [130]. Moreover, targeting CD23 with monoclonal
antibody has been shown to decrease total serum IgE level
in ∼75% of allergic asthma patients in a phase I clinical trial
and was proposed as candidate therapy for treating allergic
diseases for some patient subgroups [131]. Additional infor-
mation is needed to develop safe and eﬀective treatments
for food allergy. A better understanding of the molecular
mechanism underlying intestinal sensitization and epithelial
barrier defects may hasten the development of prophylactic
or therapeutic interventions for the management of atopic
disorders.
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